Interests: Tumor Head and Neck Cancer; Lung Cancer; Gynaecological Cance
Special Issue Information
Immunotherapy has revolutionized cancer treatment, in particular for tumors such as lung cancer and melanoma. Gynaecological cancer remains a significant cause of death with limited therapeutic options in the advanced setting. Immunotherapeutic strategies are being explored in endometrial, ovarian and cervical cancer with the view to improve patient outcomes. This special issue will focus on original studies, review articles or editorials regarding immunotherapy in gynaecological cancers. In addition, articles on cancer immunology, such as the role of immune system, biomarkers for immunotherapy response, role of tumor microenvironment in gynaecological cancers are also invited.
Dr. Panagiota Economopoulou
Manuscript Submission Information
Manuscripts should be submitted online at https://ejgo.imrpress.combyregisteringandlogging into this website. Once you are registered,click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on theInstructions for Authorspage. European Journal of Gynaecological Oncology is an international peer-reviewed open access quarterly journal published by IMR Press.